Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Zweifel

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Cancer|March 14, 2022
A Proposal for Future Modifications on Clinical TNM Staging System of Retinoblastoma Based on the American Joint Committee on Cancer Staging Manual, 7<sup>th</sup> and 8<sup>th</sup> EditionsYacoub A Yousef, Ibrahim Qaddoumi, Ibrahim Al-Nawaiseh, et al.
Ophthalmology and Therapy|September 19, 2025
Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World SettingMassimiliano Borselli, Mutasem Elfalah, Teresa Angela Trunfio, et al.
European Journal of Ophthalmology|November 9, 2021
COVID-19 outbreak and increased risk of amblyopia and epidemic myopia: Insights from EUROCOVCAT groupMario Damiano Toro, Dominique Bremond-Gignac, Antoine Pierre Brézin, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 4, 2017
SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular DegenerationFrank Enseleit, Stephan Michels, Isabella Sudano, et al.
Scientific Reports|February 1, 2024
Retinal vessel volume reference database derived from volume-rendered optical coherence tomography angiographySilvia Feu-Basilio, Peter M Maloca, Pascal Hasler, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 25, 2021
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical EndeavorMutasem Elfalah, Saif Aldeen AlRyalat, Mario Damiano Toro, et al.
Scientific Reports|March 8, 2022
Reference database of total retinal vessel surface area derived from volume-rendered optical coherence tomography angiographyPeter M Maloca, Silvia Feu-Basilio, Julia Schottenhamml, et al.
Ophthalmology. Retina|December 12, 2022
Incidence and Risk Factors of Visual Impairment in Patients with Angioid Streaks and Macular NeovascularizationMaria Vittoria Cicinelli, Edoardo Torrioli, Lamberto La Franca, et al.
The British Journal of Ophthalmology|October 8, 2025
Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study groupMariano Cozzi, Sandrine Zweifel, Konstantinos Balaskas, et al.
Ophthalmology and Therapy|October 17, 2025
One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportAnne Tillmann, Richard Stillenmunkes, Justus G Garweg, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Cancer|March 14, 2022
A Proposal for Future Modifications on Clinical TNM Staging System of Retinoblastoma Based on the American Joint Committee on Cancer Staging Manual, 7<sup>th</sup> and 8<sup>th</sup> EditionsYacoub A Yousef, Ibrahim Qaddoumi, Ibrahim Al-Nawaiseh, et al.
Ophthalmology and Therapy|September 19, 2025
Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World SettingMassimiliano Borselli, Mutasem Elfalah, Teresa Angela Trunfio, et al.
European Journal of Ophthalmology|November 9, 2021
COVID-19 outbreak and increased risk of amblyopia and epidemic myopia: Insights from EUROCOVCAT groupMario Damiano Toro, Dominique Bremond-Gignac, Antoine Pierre Brézin, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 4, 2017
SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular DegenerationFrank Enseleit, Stephan Michels, Isabella Sudano, et al.
Scientific Reports|February 1, 2024
Retinal vessel volume reference database derived from volume-rendered optical coherence tomography angiographySilvia Feu-Basilio, Peter M Maloca, Pascal Hasler, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 25, 2021
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical EndeavorMutasem Elfalah, Saif Aldeen AlRyalat, Mario Damiano Toro, et al.
Scientific Reports|March 8, 2022
Reference database of total retinal vessel surface area derived from volume-rendered optical coherence tomography angiographyPeter M Maloca, Silvia Feu-Basilio, Julia Schottenhamml, et al.
Ophthalmology. Retina|December 12, 2022
Incidence and Risk Factors of Visual Impairment in Patients with Angioid Streaks and Macular NeovascularizationMaria Vittoria Cicinelli, Edoardo Torrioli, Lamberto La Franca, et al.
The British Journal of Ophthalmology|October 8, 2025
Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study groupMariano Cozzi, Sandrine Zweifel, Konstantinos Balaskas, et al.
Ophthalmology and Therapy|October 17, 2025
One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportAnne Tillmann, Richard Stillenmunkes, Justus G Garweg, et al.
Pageof 9